Pulmonary arterial hypertension in SLE: what do we know? (Q53102154)

11 May 2018

title

Pulmonary arterial hypertension in SLE: what do we know? (English)

1 reference

11 May 2018

main subject

arterial hypertension

1 reference

2

C Gordon

1 reference

11 May 2018

A Prabu

1

1 reference

11 May 2018

publication date

1 October 2013

1 reference

11 May 2018

published in

Lupus

1 reference

11 May 2018

volume

22

1 reference

11 May 2018

issue

12

1 reference

11 May 2018

page(s)

1274-1285

1 reference

11 May 2018

Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Updated clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Guidelines for the diagnosis and treatment of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Clinical and laboratory features of scleroderma patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Pulmonary hypertension in systemic lupus erythematosus: a systematic review and analysis of 642 cases in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Pulmonary arterial hypertension in France: results from a national registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

An epidemiological study of pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Inflammation in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Echocardiographic assessment of pulmonary hypertension: standard operating procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Interstitial lung disease in systemic sclerosis: a simple staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Pulmonary hypertension: screening and evaluation in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Diagnosis and assessment of pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Prevalence of anti-endothelial cell antibodies in patients with pulmonary arterial hypertension associated with connective tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Pathobiology of pulmonary hypertension. The role of platelets and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Pulmonary arterial hypertension associated to connective tissue diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Immunosuppressive therapy in lupus- and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Prognostic factors for survival in systemic lupus erythematosus associated pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Management of pregnancy in women with pulmonary hypertension secondary to SLE and anti-phospholipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Pregnancy outcomes in pulmonary arterial hypertension in the modern management era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Echocardiographic measurement of the normal adult right ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Color Doppler evaluation of valvular regurgitation in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Usefulness of Right Ventricular Fractional Area Change to Predict Death, Heart Failure, and Stroke Following Myocardial Infarction (from the VALIANT ECHO Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Tricuspid annular displacement predicts survival in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Doppler echocardiographic index for assessment of global right ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Ventricular interdependence: significant left ventricular contributions to right ventricular systolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Comparison of Novel Echocardiographic Parameters of Right Ventricular Function with Ejection Fraction by Cardiac Magnetic Resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

Plasma coagulation profiles in patients with severe primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313505010

21 January 2018

Identifiers

DOI

10.1177/0961203313505010

1 reference

11 May 2018

1 reference

11 May 2018